Amgen Acquisition of Horizon Therapeutics Complete

Print Friendly, PDF & Email

As of October 6, 2023, Amgen officially acquired Horizon Therapeutics. For our cystinosis community using PROCYSBI as a therapeutic option, we have been informed that every attempt is being made for a smooth transition, operating “business as usual.”

“We would like to reassure you that there will be no change for patients as we remain committed to the support and service of people living with cystinosis and their communities.”

Access the formal press release here: